The combination of local ablation and intra-arterial therapies may help overcome shortcomings of monotherapy treatment for larger tumors. In addition, there is high interest in combining local therapies with targeted molecular therapies like Sorafenib. Combination of treatments, new technologies in imaging and targeted drug delivery will ultimately improve the quality of life and survival of patients.